Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
ValSource announced Dr. James Vesper has joined as a Director, Learning Solutions.
read more
Wednesday, November 27, 2019
JanOne has announced a licensing agreement for TV1001SR, a treatment for Peripheral Artery Disease.
read more
Thursday, February 06, 2020
JanOne has executed a manufacturing agreement for the formulation and manufacturing of TV1001SR, a treatment for Peripheral Artery Disease.
read more
JanOne has successfully completed the formulation of JAN101, its potential treatment for Peripheral Artery Disease expected to soon be in Phase 2b trials.
read more
Friday, September 04, 2020
JanOne has confirmed stability of its developmental batch run of JAN101.
read more
JanOne has selected its bottling and labeling partner to support upcoming clinical trials.
read more
Wednesday, April 18, 2018
Janssen has entered a new worldwide collaboration with Bristol-Myers Squibb on a program to develop and commercialize Factor XIa inhibitors, including BMS-986177.
read more
Janssen has entered into a worldwide exclusive license and collaboration agreement with Protagonist to develop, manufacture, and commercialize PTG-200.
read more
Wednesday, October 11, 2017
Janssen has established the iSTEP, an information technology toolset developed to automate investigational product supply and data management in clinical trials.
read more
Friday, February 27, 2015
Japan’s pharmaceutical market value is set to grow at a tepid Compound Annual Growth Rate (CAGR) of 1.3% from $72.8 billion in 2013 to reach $79.8 billion by 2020, driven by new product launches and the healthcare burden of the country’s aging ...
read more
Abbott has been selected by the Japanese Red Cross Society (JRC) to partner in screening the country's blood donations.
read more
Jazz Pharmaceuticals announced a definitive agreement to sell its rights related to Prialt intrathecal infusion to TerSera Therapeutics for $80 million in cash at closing.
read more
Friday, February 25, 2022
Hovione announced that the Board of Directors and the shareholders have approved the appointment of Dr. Jean-Luc Herbeaux as Hovione’s Chief Executive Officer, effective 1st April 2022.
read more
Wednesday, December 27, 2023
Jemincare, a leading pharmaceutical company from China, announced that its wholly owned subsidiary company, Shanghai Jemincare Pharmaceutical Co., Ltd., recently received 6 approvals of clinical trials for its innovative drugs in the field of cancer,...
read more
PaizaBio, Inc. has secured an agreement with Taiwan-based JHL Biotech, Inc. to provide fill-finish services for multiple JHL projects. New Mexico-based PaizaBio will provide these services to JHL through its Hangzhou, China-based strategic partner, ...
read more